Safety Study of AMG 157 in Healthy Subjects and Subjects With Atopic Dermatitis



Status:Archived
Conditions:Healthy Studies, Psoriasis, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2008
End Date:September 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 157 in Healthy Subjects and Subjects With Moderate to Severe Atopic Dermatitis


This study is a phase 1 single dose escalation study of AMG 157 in healthy subjects and
subjects with moderate to severe atopic dermatitis. The purpose of the study is to evaluate
the safety, tolerability and pharmacokinetics of AMG 157.



We found this trial at
4
sites
Clinical Trial Facility in Phoenix Arizona
Phoenix, Arizona
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Trial Facility in Bend Oregon
Bend, Oregon
?
mi
from
Bend, OR
Click here to add this to my saved trials
Clinical Trial Facility in Henderson Nevada
Henderson, Nevada
?
mi
from
Henderson, NV
Click here to add this to my saved trials
Clinical Trial Facility in San Diego California
San Diego, California
?
mi
from
San Diego, CA
Click here to add this to my saved trials